Comparable Ki67 staining and associated proliferation indexes from eMSC- and sham-treated tumors demonstrated that the tumor growth reduction was not due to a decrease in 4T1 cell proliferation (Figure 1G). This evidence concerns the gene MKI67 and neoplasm.